Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL)

被引：1
|
作者：
Li, He [1 ]
Zhang, Wanhua [1 ]
Yi, Dongni [1 ]
Ye, Yuanxin [2 ]
Xiao, Xueqiu [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Hematol Res Lab, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR-ABL; CLINICAL IMPACT; IMATINIB; RESISTANT; THERAPY;
D O I：
10.1080/10428194.2016.1225205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1007
页数：3
相关论文
共 50 条
  • [11] New ABL1 Kinase Domain Mutations in BCR::ABL1-Positive Acute Lymphoblastic Leukemia
    Li, Zixuan
    Peng, Danyue
    Deng, Jun
    Xiong, Lv
    Yin, Ping
    Hu, Jing
    Qian, Chenjing
    Yao, Lan
    Yin, Hua
    Hong, Mei
    Wu, Qiuling
    CANCER MEDICINE, 2024, 13 (20):
  • [12] Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors
    Jones, Dan
    Thomas, Deborah
    Yin, C. Cameron
    O'Brien, Susan
    Cortes, Jorge E.
    Jabbour, Elias
    Breeden, Megan
    Giles, Francis J.
    Zhao, Weiqiang
    Kantarjian, Hagop M.
    CANCER, 2008, 113 (05) : 985 - 994
  • [13] Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper
    Soverini, Simona
    Albano, Francesco
    Bassan, Renato
    Fabbiano, Francesco
    Ferrara, Felicetto
    Foa, Robin
    Olivieri, Attilio
    Rambaldi, Alessandro
    Rossi, Giuseppe
    Sica, Simona
    Specchia, Giorgina
    Venditti, Adriano
    Barosi, Giovanni
    Pane, Fabrizio
    CANCER MEDICINE, 2020, 9 (09): : 2960 - 2970
  • [14] Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH plus ) Chronic Myeloid Leukemia (CML) or PH plus Acute Lymphoblastic Leukemia (ALL): a Pharmacokinetic Study
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Roberto
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Ducassou, Stephane
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S34 - S34
  • [15] Achievement of Undetectable BCR::ABL1 (uBCR::ABL1) Is Predictive of Improved Survival in Philadelphia Chromosome Positive (Ph plus ve) Acute Lymphoblastic Leukemia (ALL) Patients Not Receiving Allogeneic Stem Cell Transplantation
    Badar, Talha
    Narra, Ravi
    Mims, Alice
    Shallis, Rory M.
    Correia, Guilherme Sacchi De Camargo
    Hunter, Cameron
    Kota, Vamsi K.
    Desai, Shreya
    Patel, Anand Ashwin
    Duvall, Adam S.
    Palmisiano, Neil
    Curran, Emily K.
    Zulfa, Omer
    Advani, Anjali S.
    Atallah, Ehab L.
    Litzow, Mark R.
    BLOOD, 2023, 142
  • [16] ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases
    Michinori Aoe
    Akira Shimada
    Michiko Muraoka
    Kana Washio
    Yoshimi Nakamura
    Takahide Takahashi
    Masahide Imada
    Toshiyuki Watanabe
    Ken Okada
    Ritsuo Nishiuchi
    Takako Miyamura
    Kosuke Chayama
    Misako Shibakura
    Megumi Oda
    Tsuneo Morishima
    International Journal of Hematology, 2014, 99 : 609 - 615
  • [17] Involvement of BCR::ABL1 in laminin adhesion of Philadelphia chromosome-positive acute lymphoblastic leukemia through upregulation of integrin α6
    Takahashi, Kazuya
    Nguyen, Thao Thu Thi
    Watanabe, Atsushi
    Sato, Hiroki
    Saito, Kinuko
    Tamai, Minori
    Harama, Daisuke
    Kasai, Shin
    Akahane, Koshi
    Goi, Kumiko
    Kagami, Keiko
    Abe, Masako
    Komatsu, Chiaki
    Maeda, Yasuhiro
    Sugita, Kanji
    Inukai, Takeshi
    CANCER REPORTS, 2024, 7 (04)
  • [18] ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases
    Aoe, Michinori
    Shimada, Akira
    Muraoka, Michiko
    Washio, Kana
    Nakamura, Yoshimi
    Takahashi, Takahide
    Imada, Masahide
    Watanabe, Toshiyuki
    Okada, Ken
    Nishiuchi, Ritsuo
    Miyamura, Takako
    Chayama, Kosuke
    Shibakura, Misako
    Oda, Megumi
    Morishima, Tsuneo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 609 - 615
  • [19] Pattern and evolution of BCR-ABL kinase domain mutations in patients with Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) developing resistance to imatinib.
    Pfeifer, H
    Wassmann, B
    Pavlova, A
    Mueller, M
    Wunderle, L
    Brueck, P
    Oldenburg, J
    Hochhaus, A
    Gschaidmeier, H
    Hoelzer, D
    Ottmann, OG
    BLOOD, 2005, 106 (11) : 46A - 47A
  • [20] Serial monitoring of BCR-ABL in newly diagnosed Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL) treated with imatinib.
    Lim, Sung-Nam
    Joo, Young-Don
    Kim, Ii-Hwan
    Lee, Won-Sik
    Lee, Sang Min
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345